Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
about
The evolution of health literacy assessment tools: a systematic reviewEducation and dementia in the context of the cognitive reserve hypothesis: a systematic review with meta-analyses and qualitative analysesA systematic review of the long-term outcome of early onset schizophreniaMethods of induction of labour: a systematic reviewPosttraumatic stress and posttraumatic stress disorder after termination of pregnancy and reproductive loss: a systematic reviewA common SMAD7 variant is associated with risk of colorectal cancer: evidence from a case-control study and a meta-analysisAntidepressants for osteoarthritisGranulocyte and granulocyte-macrophage colony stimulating factors for newly diagnosed patients with myelodysplastic syndromesThe role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis-stimulating agentsMeditation for adults with haematological malignanciesErythropoiesis-stimulating agents for myelodysplastic syndromesLow dose cytarabine monotherapy for acute myeloid leukaemiaIdiotype vaccination for Non-Hodgkin lymphomaHypomethylating agents for patients with myelodysplastic syndromeThe role of concomitant extracorporeal photopheresis for the treatment of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantationAntibiotics for the prevention of infections in cancer patients receiving myelosuppressive chemotherapy or haematopoetic stem cell transplantationHypomethylating agents for adult patients with acute myeloid leukaemiaBronchoscopy-guided antimicrobial therapy for cystic fibrosisAdditional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in people with malignant lymphoma or multiple myelomaJanus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosisNon-invasive positive pressure ventilation for acute asthma in childrenPositron emission tomography-adapted therapy for first-line treatment in individuals with Hodgkin lymphomaPrognostic models for chronic lymphocytic leukaemia: an exemplar systematic review and meta-analysisFertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasiaInterventions for reducing inflammation in familial Mediterranean feverThe effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemiaUse of reflective materials during phototherapy for newborn infants with unconjugated hyperbilirubinaemiaBed rest for pressure ulcer healing in wheelchair usersReturn to work coordination programmes for improving return to work in workers on sick leaveInterleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remissionEffects of all-trans retinoic acid (ATRA) in addition to chemotherapy for adults with acute myeloid leukaemia (AML) (non-acute promyelocytic leukaemia (APL))Antibiotic therapy for adults with neurosyphilisMindfulness-based stress reduction for women diagnosed with breast cancerColony-stimulating factors for chemotherapy-induced febrile neutropeniaEculizumab for treating patients with paroxysmal nocturnal hemoglobinuriaBias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventionsThe role of additional radiotherapy for primary central nervous system lymphomaMammalian target of rapamycin inhibitors for heart transplant patientsYoga in addition to standard care for patients with haematological malignanciesIndividual recovery expectations and prognosis of outcomes in non-specific low back pain: prognostic factor exemplar review
P2860
Q21093311-2FBB878B-4F86-430C-86FB-9526CCF8261DQ21134547-9FF7D440-3F71-4113-BBAF-EC480AA0E965Q21260322-009186C4-0F62-4D5C-9C02-0FC7989B2846Q21261353-0CFC0E30-C247-49B8-8AC1-F3E7A255A49CQ21284496-483BB7DB-4B30-49BE-83EC-4865130A3B02Q21560955-E358A552-2E3C-425F-A557-0B82D46FF2F6Q24185962-E955F501-C1B9-43DE-A93B-64601B1E16E9Q24186133-87741206-6F11-4629-8B88-8072E086CDE7Q24186166-1EE02003-207B-4F12-B68F-E106180A780CQ24186169-7947F036-561A-4FA9-9B0E-8285E5C94507Q24186244-B21A8AAD-8C8E-481D-9DAB-27080F18919EQ24186270-1A630E92-EBA5-4C99-B056-A4F8652892AFQ24186272-8F9B187F-2334-45D8-94C2-F2EF88E10E44Q24186276-829174E6-0BE2-4B04-853B-C31B5511BCF8Q24186279-9080F0B8-A1E0-4762-BD67-7BB2F2AB43F6Q24186282-B0168AEA-544D-402C-A169-41DDEDE47BC5Q24186284-4CAC8378-861E-42B7-A37F-94789DA78537Q24186413-BF1A4289-C0F8-4201-A1BF-1BD899D1E925Q24186469-B86ACAAD-7852-4AB1-A62C-10D78D109B2DQ24186554-CF17DA79-33D6-491C-9F81-11FA105D6974Q24186648-153FF267-A85D-4768-A83E-E3AD0BF3AE5FQ24186668-C7580CB6-279E-4DF1-9E0B-267D405FDE4DQ24186840-BB1AC36D-D6A6-4CF1-854E-86C135C6699DQ24186960-006896FE-AEC5-40AE-B2B5-F58DEB394555Q24187197-D27079D0-82D6-4426-ABC8-D04DEEF198CFQ24187297-16CFC38B-C62B-43B0-88F5-7A36D514B761Q24187410-F94A4FCD-22E2-4FB9-870E-3E75EF695144Q24187488-2362EF9A-4F42-4348-8FAE-2BBDDF1D3B95Q24187534-CEF7158C-0373-4499-8719-214A2FA20388Q24187927-B2E8B86C-FD5D-4268-9DD8-DE9AB650551AQ24188096-084AA8B0-EF7D-426A-AD12-B71AC420D5D9Q24188209-2E67D607-AB9E-47A5-9DDC-BC2973DA81A7Q24188348-CF4FDF9C-16B1-4A15-99C7-19D635EE6390Q24193040-1A82B3D7-5523-451B-B264-E52D8DC07891Q24193045-F7262839-7605-4698-A5BE-AB08E3F8BFF8Q24193207-A3EA6B6F-7E69-4470-8950-6DE446D075D4Q24193995-CB2ADF6B-2452-467E-BF2E-017AED10DB92Q24194002-DC25F1ED-1AA7-4414-89FA-6FA3938F3338Q24194030-7DDD1231-BCA5-4748-9DF3-C36B79537E94Q24194218-66B2600B-FC91-41DA-B534-55D5C457D9F4
P2860
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
@ast
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
@en
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
@nl
type
label
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
@ast
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
@en
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
@nl
prefLabel
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
@ast
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
@en
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
@nl
P50
P3181
P1476
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
@en
P304
P3181
P356
10.1016/J.JCLINEPI.2009.06.005
P577
2009-10-01T00:00:00Z